Cargando…
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease
Extraintestinal cancers are important complications in patients with inflammatory bowel disease (IBD). A limited number of publications are available regarding the association between IBD and urothelial cancer. The primary outcome of our study was the comparison of the prevalence of urothelial cance...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347965/ https://www.ncbi.nlm.nih.gov/pubmed/34362041 http://dx.doi.org/10.3390/jcm10153257 |
_version_ | 1783735222499540992 |
---|---|
author | Caviglia, Gian Paolo Martini, Giorgio Armandi, Angelo Rosso, Chiara Vernero, Marta Bugianesi, Elisabetta Astegiano, Marco Saracco, Giorgio Maria Ribaldone, Davide Giuseppe |
author_facet | Caviglia, Gian Paolo Martini, Giorgio Armandi, Angelo Rosso, Chiara Vernero, Marta Bugianesi, Elisabetta Astegiano, Marco Saracco, Giorgio Maria Ribaldone, Davide Giuseppe |
author_sort | Caviglia, Gian Paolo |
collection | PubMed |
description | Extraintestinal cancers are important complications in patients with inflammatory bowel disease (IBD). A limited number of publications are available regarding the association between IBD and urothelial cancer. The primary outcome of our study was the comparison of the prevalence of urothelial cancer in patients with IBD with respect to the prevalence in the general population. Secondary outcomes were the assessment of risk factors for the onset of urothelial cancer in IBD. In a retrospective study we examined the medical records of all patients with a confirmed diagnosis of IBD followed in our clinic between 1978 and 2021. For each of the patients with identified urothelial cancer, more than ten patients without cancer were analyzed. Furthermore, 5739 patients with IBD were analyzed and 24 patients diagnosed with urothelial cancer were identified. The incidence of urothelial cancer, compared with the incidence in the general population, was not significantly different (0.42% vs. 0.42%; p = 0.98). Twenty-three cases were then compared (1 case was discarded due to lack of follow-up data) against 250 controls. During the multivariate analysis, smoking (odds ratio, OR = 8.15; 95% confidence interval, CI = 1.76–37.63; p = 0.007) and male sex (OR = 4.04; 95% CI = 1.29–12.66; p = 0.016) were found as risk factors. In conclusion, patients with IBD have a similar risk of developing urothelial cancer compared to the general population, but males with a history of smoking are at increased risk. |
format | Online Article Text |
id | pubmed-8347965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83479652021-08-08 Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease Caviglia, Gian Paolo Martini, Giorgio Armandi, Angelo Rosso, Chiara Vernero, Marta Bugianesi, Elisabetta Astegiano, Marco Saracco, Giorgio Maria Ribaldone, Davide Giuseppe J Clin Med Article Extraintestinal cancers are important complications in patients with inflammatory bowel disease (IBD). A limited number of publications are available regarding the association between IBD and urothelial cancer. The primary outcome of our study was the comparison of the prevalence of urothelial cancer in patients with IBD with respect to the prevalence in the general population. Secondary outcomes were the assessment of risk factors for the onset of urothelial cancer in IBD. In a retrospective study we examined the medical records of all patients with a confirmed diagnosis of IBD followed in our clinic between 1978 and 2021. For each of the patients with identified urothelial cancer, more than ten patients without cancer were analyzed. Furthermore, 5739 patients with IBD were analyzed and 24 patients diagnosed with urothelial cancer were identified. The incidence of urothelial cancer, compared with the incidence in the general population, was not significantly different (0.42% vs. 0.42%; p = 0.98). Twenty-three cases were then compared (1 case was discarded due to lack of follow-up data) against 250 controls. During the multivariate analysis, smoking (odds ratio, OR = 8.15; 95% confidence interval, CI = 1.76–37.63; p = 0.007) and male sex (OR = 4.04; 95% CI = 1.29–12.66; p = 0.016) were found as risk factors. In conclusion, patients with IBD have a similar risk of developing urothelial cancer compared to the general population, but males with a history of smoking are at increased risk. MDPI 2021-07-23 /pmc/articles/PMC8347965/ /pubmed/34362041 http://dx.doi.org/10.3390/jcm10153257 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Caviglia, Gian Paolo Martini, Giorgio Armandi, Angelo Rosso, Chiara Vernero, Marta Bugianesi, Elisabetta Astegiano, Marco Saracco, Giorgio Maria Ribaldone, Davide Giuseppe Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease |
title | Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease |
title_full | Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease |
title_fullStr | Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease |
title_full_unstemmed | Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease |
title_short | Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease |
title_sort | risk factors of urothelial cancer in inflammatory bowel disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347965/ https://www.ncbi.nlm.nih.gov/pubmed/34362041 http://dx.doi.org/10.3390/jcm10153257 |
work_keys_str_mv | AT cavigliagianpaolo riskfactorsofurothelialcancerininflammatoryboweldisease AT martinigiorgio riskfactorsofurothelialcancerininflammatoryboweldisease AT armandiangelo riskfactorsofurothelialcancerininflammatoryboweldisease AT rossochiara riskfactorsofurothelialcancerininflammatoryboweldisease AT verneromarta riskfactorsofurothelialcancerininflammatoryboweldisease AT bugianesielisabetta riskfactorsofurothelialcancerininflammatoryboweldisease AT astegianomarco riskfactorsofurothelialcancerininflammatoryboweldisease AT saraccogiorgiomaria riskfactorsofurothelialcancerininflammatoryboweldisease AT ribaldonedavidegiuseppe riskfactorsofurothelialcancerininflammatoryboweldisease |